Minimal residual disease assessment in acute lymphoblastic leukemia by 4-color flow cytometry: Recommendations from the MRD Working Group of the Brazilian Society of Bone Marrow Transplantation Maura R.V. Ikoma-Colturato; Miriam P. Beltrame; Felipe M. Furtado; Glicinia Pimenta; Elaine Sobral da Costa; Ana Paula Azambuja; Mariester Malvezzi; Mihoko Yamamoto;

All about blinatumomab: the bispecific T cell engager immunotherapy for B cell acute lymphoblastic leukemia Reza Mirfakhraie; Bentolhoda Kuhestani Dehaghi; Mahmoud Dehghani Ghorbi; Haniyeh Ghaffari-Nazari; Mozhdeh Mohammadian; Maryam Salimi; Maria Tavakoli Ardakani; Sayeh Parkhideh;

Influence of minimal residual disease by multiparametric flow cytometry at day 15 of induction in risk stratification of children with B-cell acute lymphoblastic leukemia treated at a referral hospital in southern Brazil Klerize Anecely de Souza Silva; Fabiane Spagnol; Mariela Granero Farias; Ana Paula Alegretti; Mariana Bohns Michalowski; Liane Esteves Daudt;